Warburg Pincus has closed its latest global flagship fund, Warburg Pincus Global Growth 14 (WPGG 14), with $17.3 billion of capital. PGG 14 is the largest-ever fundraise in the firm’s 57-year history, exceeding the previous global flagship fund, Warburg Pincus Global Growth, which closed on $15 billion in 2018.
WPGG 14 was launched in 2021, targeting a fund size of $16 billion.
Significant investments made to date in WPGG 14 include Simtra BioPharma Solutions (formerly Baxter’s BioPharma Solutions business), Ensemble Health, EverBank, Internet Brands, Norstella, Oona Insurance, ParetoHealth and Watertec India.
“This is a challenging period for investors, with rising rates and geopolitical tension but also new promise from this wave of innovation. This puts a premium on diversification, a careful and disciplined approach to investing, and deep expertise on the shifting frontiers of technology, across sectors and economies. We look forward to continuing to n